For a hemodynamically stable patient with atrial fibrillation undergoing electrical cardioversion, what initial shock energy should be used with biphasic versus monophasic defibrillators?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atrial Fibrillation Cardioversion Energy Recommendations

Direct Answer

For hemodynamically stable atrial fibrillation, start with 120-200 J for biphasic defibrillators or 200 J for monophasic defibrillators, with biphasic waveforms strongly preferred due to superior efficacy and lower energy requirements. 1, 2

Initial Energy Settings by Defibrillator Type

Biphasic Defibrillators (Preferred)

Start with 120-200 J for the initial shock, with the specific energy depending on AF duration: 3, 2

  • AF ≤2 days duration: Start at 100 J, which achieves 60-77% first-shock success 4, 5
  • AF >2 days duration: Start at 150-200 J for optimal outcomes 5
  • Long-standing persistent AF: Use 200 J initially, as lower energies have significantly reduced efficacy (20% success with chronic AF) 6, 4

Monophasic Defibrillators (If Biphasic Unavailable)

Start with 200 J, escalating to 360 J if needed, though this requires significantly more total energy than biphasic approaches 3, 7

  • First shock: 200 J (70% success rate) 7
  • Second shock: 360 J (90% cumulative success) 7
  • Mean cumulative energy: 306 J versus 159 J for biphasic 7

Escalation Protocol

If initial shock fails, escalate energy systematically while waiting at least 1 minute between shocks: 1, 2

Biphasic Escalation

  • 50 J → 100 J → 150 J → 200 J maximum 1
  • Alternative protocol: 100 J → 150 J → 200 J 4
  • 120 J → 200 J protocol achieves 90% success with rectilinear biphasic waveforms 7

Monophasic Escalation

  • 100 J → 200 J → 300 J → 360-400 J maximum 1

Critical Technical Considerations

Electrode Positioning

Use anterior-posterior configuration rather than anterior-lateral positioning for superior outcomes: 1, 2

  • Anterior-posterior: 87% overall success rate 1
  • Anterior-lateral: 76% overall success rate 1
  • Anterior-posterior requires less total energy 1, 2

Waveform Superiority

Biphasic waveforms are definitively superior to monophasic for atrial fibrillation cardioversion: 3, 4, 8

  • Biphasic achieves 90% success at 200 J versus 53% for monophasic 4
  • Biphasic 200 J equals monophasic 360 J in efficacy (91% vs 85%) 4
  • Biphasic requires fewer total shocks (1.5 vs 2.9) and lower cumulative energy (203 J vs 570 J) 8
  • Biphasic causes less dermal injury with no blistering 4

Clinical Algorithm

  1. Assess AF duration to determine optimal starting energy 6, 5
  2. Identify defibrillator type: Biphasic (modern) or monophasic (older) 1, 2
  3. Position electrodes in anterior-posterior configuration 1, 2
  4. Select initial energy:
    • Biphasic: 100 J (short duration) or 150-200 J (longer duration) 5
    • Monophasic: 200 J 7
  5. Escalate systematically if initial shock fails 1, 4
  6. Wait ≥1 minute between consecutive shocks to prevent myocardial damage 1, 2

Important Caveats

Duration-Dependent Success

AF duration is the only independent predictor of low-energy cardioversion success (r = -0.51, p = 0.02): 6

  • AF <48 hours: 80% success with biphasic shocks 4
  • AF >48 hours: 63% success 4
  • AF >1 year: Only 20% success, requiring higher initial energies 4

Sedation Requirements

Ensure adequate sedation or anesthesia before cardioversion using short-acting agents for rapid recovery 2

Comparison with Atrial Flutter

Do not confuse AF energy requirements with atrial flutter, which requires significantly higher energies (120-200 J biphasic or 200 J monophasic for flutter versus 50-100 J for fibrillation) 1, 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.